TMX (PK) Quote - TMXXF | ADVFN

S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Home
Investing
Stocks
USA
USOTC
TMX Group Ltd (PK) (TMXXF) Share Price

TMX Group Ltd (PK) (TMXXF)

31.36

0.00

( 0.00% )

Updated: 13:28:01

Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Current Price

31.36

Bid

31.48

Ask

31.51

Volume

86

0.00 Day's Range 0.00

20.69 52 Week Range 32.67

Market Cap

Previous Close

31.36

Open

-

Last Trade

Last Trade Time

11:38:41

Financial Volume

-

VWAP

-

Average Volume (3m)

24,547

Shares Outstanding

277,586,235

Dividend Yield

3.39%

PE Ratio

33.17

Earnings Per Share (EPS)

1.33

Revenue

608.1M

Net Profit

368M

Sector

Security,commodity Exchanges

Industry

Security,commodity Exchanges

Website

www.tmx.com

Headquarters

Toronto, Ontario, Can

Founded

-

TMX Group Ltd (PK) is listed in the Security,commodity Exchanges sector of the OTCMarkets with ticker TMXXF. The last closing price for TMX (PK) was US$31.36. Over the last year, TMX (PK) shares have traded in a share price range of US$ 20.69 to US$ 32.67.

TMX (PK) currently has 277,586,235 shares outstanding. The market capitalization of TMX (PK) is US$8.71 billion. TMX (PK) has a price to earnings ratio (PE ratio) of 33.17.

No news to show yet.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.269	-0.85048531411	31.629	31.629	30.85	14822	30.92453642	CS
4	0.39	1.25928317727	30.97	32.518	30.85	19979	31.54208092	CS
12	-0.23	-0.728078505856	31.59	32.67	28.86	24547	31.55669973	CS
26	4.46	16.5799256506	26.9	32.67	26.7	29197	30.12000714	CS
52	10.25	48.5551871151	21.11	32.67	20.69	24783	28.32580747	CS
156	10.38199969	49.4899396348	20.97800031	32.67	18.20500027	13685	26.3527173	CS
260	14.49599975	85.9582515127	16.86400025	32.67	12.61600019	8638	25.97407219	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
AGDXFAntioqua Gold Inc (CE)	US$ 0.02 (1,999,900.00%)	2.5k
ISUNQiSun Inc (CE)	US$ 0.0007 (69,900.00%)	19.21k
TTCFQTattooed Chef Inc (CE)	US$ 0.0002 (19,900.00%)	51.12k
YAYOYayYo Inc (CE)	US$ 0.0001 (9,900.00%)	2.83k
ECPNEl Capitan Precious Metals Inc (CE)	US$ 0.0001 (9,900.00%)	2.25k
EGBBEarth Gen Biofuel Inc (CE)	US$ 0.000001 (-99.95%)	8k
CNVIFConavi Medical Corporation (PK)	US$ 0.0007 (-99.88%)	1.93k
SPRNSupernova Energy Inc (CE)	US$ 0.000001 (-99.67%)	2k
SCNGSC Holdings Corporation (CE)	US$ 0.000001 (-99.50%)	55k
FUNFFFansUnite Entertainment Inc (CE)	US$ 0.000001 (-99.50%)	2.4k
GRLFGreen Leaf Innovations Inc (PK)	US$ 0.0001 (0.00%)	210.2M
HCMCHealthier Choices Management Corporation (PK)	US$ 0.00005 (4,900.00%)	115.06M
THBDThird Bench Inc (PK)	US$ 0.0003 (200.00%)	112.63M
QEDNQED Connect Inc (PK)	US$ 0.0005 (25.00%)	78.09M
RDARRaadr Inc (PK)	US$ 0.0007 (16.67%)	70.75M

manibiotech

manibiotech 1 minute ago

However the data of current trial submitted for approval is not "in vitro"

payupdeadbeat

payupdeadbeat 1 minute ago

It is clear that the "investment of a lifetime* message is not getting out. I hope the longs are not being hornscwaggled.

Craig305

Craig305 1 minute ago

This is the highest day volume since June 2022.

Serpico2005

Serpico2005 2 minutes ago

HUGE revenue pouring in here, we won't be denied, won't be able the hold it down much longer.

delerious1

delerious1 2 minutes ago

Milling results soon yet some say that this stock is garbage etc have been here as long as me or longer so that would mean plenty of time to see the patterns and make some really good money....but I bet that they haven't....so it is a bit of a conundrum....why wouldn't they when obviously given the

ExtremelyBullishZig

ExtremelyBullishZig 2 minutes ago

No...all biotechs are up based on gene editing company success it move the index

richme

richme 2 minutes ago

Need to Curb Your Enthusiasm just because the share price jumped all the way to $0.0166 share price,
-$0.0015 day change. Isn't that great? We will be heading to Mars soon....no less in Elon Musk's rocket ship or to hell in ________ (add your own).

Quintessence

Quintessence 2 minutes ago

PDYNW - Nice move today! I will consider buying dips.

JRoon71

JRoon71 2 minutes ago

TC, I get that. I just meant that in looking at what Italy pays for other drugs, what Amarin wants for Vazkepa is substantially more than MOST drugs on the list.

I'm not talking about the cost to patients, but the cost to the government.

If Vazkepa cost $15 to sell to

dennisdave

dennisdave 3 minutes ago

BTW, the three companies with approved PD1 inhibitors, which is what the U.S. patent office tried to narrow the combo patent to, are:

Merck = Keytruda

Opdivo = Bristol

Libtayo = Regeneron.
Thanks very helpful.

attilathehunt

attilathehunt 3 minutes ago

1 buy of 20k will work the same as 2 buys of 10k on squeeze day, no?

NO!!!!!

On squeeze day your first buy order will be much much lower than all subsequent ones...

For example, on Squeeze day (approval) if your first early open trade gets executed at 1.0

bgATL

bgATL 3 minutes ago

Gaetz is out, my opinion has been he was never really going to be in the position, as it was cover to let him resign from the House before the severe reprimands which could have ruined his chances of a future career. Trump also could now argue he tried to put a pot friendly guy in the office and it

Pic 3 minutes ago

I wonder if .0011 is a good entry? Fishing time. 🎣

konshe

konshe 3 minutes ago

Strong buy at ask 0.0002, paint sell at bid 0.0001. 0.0002 2mm shares will be gone soon.

al44

al44 3 minutes ago

The world will become safer when the ‘adults in the room’ are… gone

By Jack Hellner

When Biden and his team of incompetents took over, the media cheered that finally the adults were back in the room; well thankfully, the “children” will be back soon and the U.S.

Real McCoy

Real McCoy 4 minutes ago

I think they think that announced participation in a hot industry segment should entitle them to valuation levels of those hot industry segment leaders. Despite ALWAYS having virtually no revenue.

KRISGO

KRISGO 4 minutes ago

Hello Dcaf7, based on the full abstract being released on Nov 25th, can the experts evaluate whether same-day dosing is effective and works better?

PennyMillions852

PennyMillions852 4 minutes ago

BID building here but...you KNOW what will come next......this is the type of chit that needs to stop for us to move up above .0003!

Hitman970

Hitman970 4 minutes ago

Why hasn't this historic moment made any mainstream press?
x / twitter and company generate PRs mean nothing.
You are repeating yourself over and over. Do you know Vic? You called him "benign" a while back.

CrashOverride

CrashOverride 4 minutes ago

If it was DCVax the 2016 paper would cite Liau or Prins as they are the leaders in the field of Dendritic-cell-based vaccines.

They had several papers published before 2016.

It doesn't so it isn't DCVax.

biotechinvestor1

biotechinvestor1 4 minutes ago

From another poster: “Evotec has already said no thanks. Wall Street said no thanks. When Halozyme management says ok forget about it, we go up $10. We are waiting Ms Helen.”

BamaBreeze

BamaBreeze 4 minutes ago

Can you bring in the update your referencing(please).

redspinelpinktopaz

redspinelpinktopaz 4 minutes ago

No. It seems all right to me.

glenn1919

glenn1919 4 minutes ago

TRNR....CISO....MULN.........................https://stockcharts.com/h-sc/ui?s=MULN&p=D&yr=0&mn=2&dy=12&id=p84071410134

WinstonCup

WinstonCup 4 minutes ago

Sometimes you make no sense.

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions